INTRODUCTION
Most micro-organisms exist in nature as complex communities attached to surfaces rather than as isolated free-floating planktonic organisms. These structurally and functionally complex communities, termed biofilms, consist of one or more microbial species encased in an extracellular polymeric substance, and attached to one another or to a solid surface (Samaranayake & MacFarlane, 1990) . Biofilms, in comparison to their planktonic counterparts, are resistant to antimicrobials (Mah & O'Toole, 2001; O'Toole et al., 2000) , and are thought to be involved in up to 65 % of all human microbial infections (McLean et al., 2004) .
LPS, a bacterial endotoxin, is an amphiphilic molecule, which is heterogeneous both in size and composition (Aurell & Wistrom, 1998) . It is an outer cell wall component of Gram-negative bacteria that initiates septic shock in humans and animals through its proinflammatory and immunomodulatory properties (Aurell & Wistrom, 1998; Rietschel et al., 1982) . LPS also induces a variety of responses in monocytes and polymorphonuclear cells, which may play a role in the mechanism of endotoxic shock (Michalek et al., 1980; Tracey et al., 1987) ; other manifestations of LPS may play a role in the pathophysiology of infections Young, 1985) .
The interactions between LPS and Candida have been sparsely investigated. In previous studies, Henry-Stanley et al. (2003) demonstrated that Escherichia coli LPS enhances the lethality of parenterally administered C. albicans. Palma et al. (1992) , in an in vitro study, showed that LPS from E. coli, Serratia marcescens and Salmonella typhimurium, at doses ranging from 1 to 100 ng ml 21 , strongly enhanced the inhibitory response of human polymorphonuclear leukocytes against the growth of C. albicans. Furthermore, the number of yeasts ingested per neutrophil, as well as the number of neutrophils capable of ingesting fungal cells, was markedly increased as a result of LPS exposure (Palma et al., 1992) . Our group recently demonstrated, for the first time, the direct modulatory effect of E. coli LPS on different stages of Candida biofilm formation. E. coli LPS significantly suppressed the initial colonization of Candida dubliniensis, while it enhanced the initial colonization of C. tropicalis and maturation of C. parapsilosis biofilms (Bandara et al., 2009) .
Numerous in vivo and in vitro studies have shown that various bacteria and Candida have complex interactions in mixed-species biofilms. This suggests that bacterial infections may play a modulatory role in Candida infections (Bandara et al., 2009; Hedderwick et al., 2000; Peres-Bota et al., 2004) . However, the role of the major Gram-negative bacterial endotoxin, LPS, in mixed infections is yet to be fully unravelled. Though a few studies have been conducted, none have been designed to illustrate the effect of LPSs on the process of biofilm formation of this yeast. Furthermore, the role of different Gram-negative bacterial LPS on candidal biofilms has not been evaluated. Additionally, the majority of the previous studies have focused only on C. albicans and, to the best of our knowledge, there are no studies pertaining to non-albicans Candida spp. biofilms.
Hence, the aims of this study were to evaluate the effect of LPS derived from Pseudomonas aeruginosa, Serratia marcescens, Klebsiella pneumoniae and Salmonella typhimurium on six different Candida species, including C. albicans, C. glabrata, C. tropicalis, C. parapsilosis, C. dubliniensis and C. krusei, in different stages of biofilm formation, by both quantitative assays (XTT reduction assay), and qualitative evaluations using scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM).
METHODS
Experimental design. The study comprised a series of multiple experiments to evaluate the effect of LPS derived from different Gram-negative bacteria as described below, on Candida spp. biofilm formation, quantitatively with XTT reduction assay, and qualitatively with CLSM and SEM, at three different time intervals, 90 min, 24 h and 48 h. These time intervals corresponded to the adhesion phase, initial colonization phase and the maturation phase of Candida biofilms, respectively. These latter definitions and terminology are used consistently in the following sections of the paper.
Micro-organisms. The following reference laboratory strains of Candida were used: C. albicans ATCC 90028, C. glabrata ATCC 90030, C. tropicalis ATCC 13803, C. parapsilosis ATCC 22019, C. krusei ATCC 6258 and C. dubliniensis MYA 646. The identity of each organism was confirmed with the commercially available API 32 C identification system (bioMérieux). Prior to experiments, all isolates were stored in multiple aliquots at 220 uC, after confirming their purity.
LPS. LPSs purified by phenol extraction from K. pneumoniae ATCC 15380 (catalogue no. L4268), Serratia marcescens ATCC 21639 (catalogue no. L6136), Salmonella typhimurium ATCC 7823 (catalogue no. L6511), and P. aeruginosa ATCC 27316 (catalogue no. L9143) were purchased in the form of lyophilized powder from Sigma Aldrich and stored 2-8 uC until use.
Growth media. Sabouraud dextrose agar and yeast nitrogen base (YNB) solution supplemented with 100 mM glucose were used for culturing Candida species.
Microbial inocula. Prior to each experiment, Candida spp. were subcultured on Sabouraud dextrose agar for 18 h at 37 uC. A loopful of this overnight Candida growth was inoculated into YNB medium and incubated for 18 h in an orbital shaker (75 r.p.m.) at 37 uC. The resultant growth was harvested, washed twice in PBS (pH 7.2, Ca 2+ and Mg 2+ free; Sigma) and resuspended. PBS without calcium and magnesium ions was used to wash and rinse suspended cells as these ions facilitate cell binding and clumping, which will mask the effect of LPS on Candida during biofilm development. Concentrations of Candida spp. were adjusted 1610 7 cells ml 21 by spectrophotometry and confirmed by haemocytometric counting.
Biofilm formation. Candida biofilms were prepared as described by Jin et al. (2004) , with some modifications. Commercially available presterilized, polystyrene, flat bottom 96-well microtitre plates (Iwaki) were used. At first, 100 ml standard cell suspension of Candida spp. (10 7 organisms ml
21
) was prepared and transferred into the wells of a microtitre plate, and the plate incubated for 1.5 h at 37 uC in an orbital shaker at 75 r.p.m. to promote microbial adherence to the surface of the wells. After the initial adhesion phase, the cell suspensions were aspirated and each well was washed twice with PBS to remove loosely adherent cells. A total of 200 ml YNB was transferred to each well and the plate reincubated for 24 and 48 h, and the wells washed twice and three times at the respective time intervals with PBS to eliminate traces of YNB. Thus, the effect of bacterial LPS on Candida was studied at 90 min, 24 h and 48 h time intervals.
Quantitative analyses -evaluation of LPS impact using XTT reduction assay. Freshly obtained LPS (1 mg ml 21 ; Sigma Aldrich) and YNB supplemented with 100 mM glucose were prepared to yield a final dilution of LPS ranging from 100 mg ml 21 to 1 ng ml
. LPS was replaced with sterile PBS in the control samples. Candida biofilms were formed in three different 96-well plates to evaluate the effect of LPS at 90 min, 24 h and 48 h ( Fig. 1) as described below.
First, a Candida suspension (100 ml each) resuspended in test and control media (see above) was dispersed into selected wells of a 96-well plate at time 0 and incubated in an orbital shaker (75 r.p.m.) at 37 uC for 90 min for the adhesion assay. In the second assay, 200 ml test and control media were added at 90 min to a different 96-well plate with pre-adherent Candida and incubated for 24 h for the initial colonization study. Finally, in the third assay, the latter procedure was repeated at 24 h for initially colonized Candida, in a different 96-well plate, and incubated for further 24 h for the maturation phase study.
At the end of incubation, the supernatant was removed and wells washed twice with sterile PBS to remove loosely adherent cells. A standard XTT reduction assay was performed thereafter as described by Jin et al. (2004) to measure the metabolic activity of the biofilms. In brief, commercially available XTT powder (Sigma) was dissolved in PBS at a final concentration of 1 mg ml
, then the solution was filter-sterilized (0.22 mm pore size filter) and stored at 270 uC. Freshly prepared 0.4 mM menadione solution was used for the assay. XTT solution was thawed and mixed with menadione solution at 20 : 1 (v/v) immediately before the assay. Thereafter, 158 ml PBS, 40 ml XTT and 2 ml menadione solution were added into each well containing prewashed biofilms and incubated in the dark for 3 h at 37 uC. The colour change was measured by absorbance with a microtitre plate reader (Spectra Max 340 tunable microplate reader; Molecular devices) at 492 nm. All assays were carried out in triplicate on three different occasions.
Qualitative analyses. CLSM (Jin et al., 2005) and SEM were used to observe the ultrastructure of test and control Candida biofilms (Fig. 1 ).
CLSM. Commercially available presterilized flat-bottomed six-well plates (Iwaki) and presterilized plastic coverslips (Thermanox; Nulge Nunc International) (Ramage et al., 2001) were used to prepare biofilms as described above. Presterilized coverslips were placed in the wells of a six-well plate, Candida suspensions added and the plate incubated for 90 min (the adhesion phase) in an orbital shaker (75 r.p.m.) at 37 uC. Thereafter, the supernatant was removed, washed twice with PBS, fresh YNB added and incubated for 24 h (initial colonization) or 48 h (maturation) under the same environmental conditions. At the end of each time interval, the prewashed coverslips were stained with LIVE/DEAD stain (LIVE/DEAD BacLight Bacterial viability kit; Invitrogen) (Jin et al., 2005) . The biofilm was then analysed by fluorescent microscopy (using a confocal laser scanning microscope).
SEM. For SEM, we prepared Candida species biofilms (both control and LPS treated) on custom-made, tissue culture-treated, polystyrene coverslips (prepared in six-well plates) as described above. At 90 min, 24 h and 48 h, selected coverslips were removed from the wells, washed twice with PBS and placed in 1 % osmium tetroxide for 1 h. Samples were subsequently washed in distilled water, dehydrated in a series of ethanol washes (70 % for 10 min, 95 % for 10 min and 100 % for 20 min), and air-dried in a desiccator prior to sputter coating with gold. Then the specimens were mounted on aluminium stubs, with copper tape, and coated with gold under low-pressure with an ion sputter coater (JFC1 100; JEOL). The surface topographies of the biofilm were visualized with a scanning electron microscope (Philip XL30CP) in high-vacuum mode at 10 kV, and the images processed.
Statistical analysis. Statistical analysis was performed using SPSS software (version 16.0). The Mann-Whitney U-test was performed to compare significant differences between the control and each test sample of the candidal biofilm. Data from all Candida spp. at different time points (90 min, 24 h and 48 h) were pooled and evaluated against a concentration gradient of different LPS using 2-sample t-test. A similar statistical test was used to analyse pooled data from all LPS experiments at a concentration gradient against different Candida spp. at different time points (90 min, 24 h and 48 h). A P value of ,0.05 was considered statistically significant.
RESULTS

Effect of E. coli LPS on Candida biofilms (XTT reduction assay)
In the early biofilm development phase, after 90 min of incubation, some of the LPS-treated Candida species demonstrated significant changes in metabolic activity Fig. 1 . Summary of the experimental design. Candida biofilm formation was evaluated at three different time intervals: 0-90 min (adhesion phase), 90 min-24 h (initial colonization phase) and 24-48 h (maturation phase). At the commencement of each time interval, varying concentrations of LPS were added to Candida biofilms in 96-well plates; at the end of each phase, quantitative and qualitative analyses were performed using the XTT reduction assay, and CLSM and SEM, respectively.
Bacterial LPS modulates Candida biofilms compared with their controls. With Pseudomonas LPS, C. albicans showed significant enhancement of its metabolic activity at 10 mg ml 21 and in contrast, C. glabrata was significantly inhibited at 100 mg ml
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, 10 mg ml 21 , 100 ng ml 21 and 10 ng ml
. Adhesion of the other four Candida species were unaffected with Pseudomonas LPS treatment. With Serratia LPS, C. tropicalis was the only species affected out of all six Candida species, and demonstrated significantly reduced XTT readings at the concentrations of 100 mg ml 21 , 10 mg ml 21 and 1 mg ml
. With Salmonella LPS, a similar effect was observed in the adhesion phase of C. glabrata at 100 mg ml 21 and 10 mg ml 21 , C. parapsilosis at 100 mg ml 21 and C. dubliniensis at 10 mg ml
, while the adhesion of C. albicans, C. tropicalis and C. krusei remained unaffected. In contrast, Klebsiella LPS significantly increased the metabolic activity of only C. albicans early biofilms at 10 mg ml 21 concentration (Table 1, Supplementary Tables S1, S2 , S3, S4, S5 and S6 available with the online journal).
However, after prolonged incubation, for 24 h, beyond the initial colonization phase of the biofilms, significant variations in XTT readings were seen in all Candida spp. Thus, upon Pseudomonas LPS treatment, C. glabrata at 100 mg ml 21 , 10 mg ml 21 and 1 ng ml
, and C. dubliniensis and C. krusei at 100 mg ml 21 showed significantly reduced XTT values. C. albicans, C. tropicalis and C. parapsilosis showed uninterrupted colonization at this stage. A stimulatory effect was detected in C. krusei biofilms treated with 10 mg Serratia LPS ml 21 and the colonization of remaining five Candida species was unaffected. C. dubliniensis treated with 100 mg Klebsiella LPS ml 21 also demonstrated a significant reduction in XTT readings. In contrast, Klebsiella LPS-treated biofilms of C. albicans at 100 mg ml 21 , and C. glabrata at 10 mg ml 21 and 1 mg ml
, showed a significant stimulation of metabolic activity, whilst C. tropicalis, C. parapsilosis and C. krusei showed normal biofilm growth. Salmonella LPS also had a similar stimulatory effect on C. glabrata at 100 ng ml 21 , on C. tropicalis at 100 mg ml 21 and 10 ng ml
, and on C. krusei at 1 ng ml
. However, Salmonella LPS significantly lowered the metabolic activity of C. parapsilosis at 100 ng ml 21 , and C. dubliniensis and C. krusei at 100 mg ml
. C. albicans could withstand the effects of Salmonella LPS at this stage (Table 1) .
On further incubation for 48 h, Pseudomonas LPS demonstrated a significant suppression of metabolic activities of C. parapsilosis (at 100 mg ml
, 10 mg ml 21 and 100 ng ml 21 ), C. dubliniensis (at 100 mg ml 21 ) and C. krusei (at 100 mg ml 21 , 10 mg ml 21 100 ng ml 21 and 1 ng ml
); although, the maturation of C. albicans, C. glabrata and C. tropicalis biofilms were unaffected in the presence of Pseudomonas LPS. In contrast, when treated with Serratia LPS, an elevated metabolic activity could be observed in C. glabrata (at 100 mg ml 21 and 10 ng ml 21 ), and C. tropicalis (at 100 mg ml
, 10 mg ml 21 and 1 mg ml
). Conversely, C. parapsilosis showed the opposite response at 100 mg ml 21 though C. albicans, C. dubliniensis and C. krusei biofilms were unaffected. When treated with Klebsiella LPS, C. glabrata (at 10 mg ml 21 ), and C. dubliniensis (at 100 mg ml
) demonstrated significantly low XTT readings compared to the controls, though a significantly higher reading was noted with C. parapsilosis (at 100 mg ml 21 and 10 mg ml
) and C. dubliniensis (at 100 ng ml 21 and 10 ng ml
). The remaining three Candida species tested were unaffected. A significant increase in the metabolic activity of C. glabrata was observed after treatment with Salmonella LPS (at 100 mg ml
, 1 mg ml 21 and 100 ng ml 21 concentrations). In contrast, a lower XTT reading was detected in C. dubliniensis biofilms treated with 100 mg Salmonella LPS ml
. C. albicans, C. parapsilosis and C. dubliniensis biofilms showed normal maturation despite the treatment with Salmonella LPS (Table 1) .
We further analysed the pooled data from the foregoing experiments due to the high variability of the results. This was performed in two ways: first, the data from all Candida species against LPS of different Gram-negative bacterial species were pooled and analysed; second, the data from all bacterial LPS against six different Candida spp. were pooled and analysed.
In the first analysis, after 90 min of incubation (adhesion phase) Salmonella LPS at 100 mg ml 21 and 10 mg ml 21 significantly suppressed the metabolic activity of Candida spp. in general. However, the remaining types of LPS tested, at any given concentration, had no significant effects on the adhesion (90 min), initial colonization (24 h) or biofilm maturation (48 h) of Candida species.
Furthermore, when the data from all the tests of bacterial LPS against six different Candida spp. were pooled and analysed, we noted that the metabolic activity of the C. albicans 24 h biofilm was significantly higher when treated with 100 mg LPS ml
. In contrast, at a similar concentration of LPS, C. dubliniensis 24 h and 48 h biofilms, and C. krusei 24 h biofilm demonstrated a significant reduction in the metabolic activity. C. glabrata, C. tropicalis and C. parapsilosis in all three stages of biofilm formation could withstand any given concentration of LPS without any significant effect.
CLSM
CLSM with LIVE/DEAD stain showed an increase in C. albicans blastospores after incubation with Pseudomonas LPS for 90 min, confirming the data from XTT reduction assay (Fig. 2a, b) . Furthermore, LPS-treated C. albicans were uniform in size, clumped and showed a higher proportion of budding yeasts compared to its control (Fig. 2b) , whilst a considerable number of dead yeasts were visible among scattered C. albicans in the control (Fig. 2a) .
After 24 h of incubation (initial colonization phase), growth suppression of C. krusei by Salmonella LPS was clearly seen by CLSM with LIVE/DEAD stain, confirming the XTT reduction assay data (Fig. 2c, d) . Thus a few, scant C. krusei blastospores were scattered in the microscopic field. Yeasts were small in size and few showed budding morphology. Some dead and degrading cells were also present in sparsely visible matrix (Fig. 2d) . In contrast, its control counterpart showed a higher proportion of uniform and elongated C. krusei blastospores arranged in clusters (Fig. 2c) . Similarly, at the same time point (Fig. 2e,  f) , groups of irregular shaped blastospores of C. glabrata were visible in the Pseudomonas LPS-treated (100 mg ml 21 ) sample (Fig. 2f) , while the C. glabrata control was densely populated with uniform yeasts (Fig. 2e) .
After 48 h of incubation (maturation phase), sparsely distributed C. dubliniensis blastospores were noted in biofilms treated with Salmonella LPS, reconfirming the foregoing quantitative (XTT) findings (Fig. 2g, h ). Yeasts were anisotropic, with some cellular debris in the background (Fig. 2h) compared to the control where high numbers of C. dubliniensis yeast forms and some hyphae were evident (Fig. 2g) .
SEM
After 90 min of incubation (adhesion phase), increased numbers of blastospores adherent to the polystyrene surface were noted in C. albicans treated with Pseudomonas LPS (100 mg ml 21 ) (Fig. 3a, b) . Yeasts of varying sizes were noted and some with irregular cell profiles appeared to be degrading (Fig. 3b) . In contrast, the C. albicans control had lesser numbers of yeasts of more uniform size, and healthier than those treated with LPS (Fig. 3a) .
After 24 h of incubation, the C. dubliniensis control characteristically exhibited a profuse, dense growth; although, the extracellular matrix was scarcely visible under SEM. Yeasts were uniform in appearance (Fig. 3c) . However, C. dubliniensis treated with Pseudomonas LPS (100 mg ml
21
) showed a scanty biofilm with reduced numbers of cell layers and reduced cell regularity. Yeasts were different in size and shape (Fig. 3d) .
After 48 h of incubation for biofilm maturation, C. krusei biofilm controls demonstrated elongated, more uniform yeasts with a substantial amount of extracellular matrix. Some dead and degrading cells could also be observed under SEM (Fig. 3e) . In contrast, C. krusei treated with Pseudomonas LPS (100 mg ml
) showed a scanty biofilm with elongated blastospores and sparse extracellular matrix (Fig. 3f) .
DISCUSSION
Candida is a polymorphic fungus that frequently causes systemic infections in critically ill patients . Despite advances in antifungal therapy, the upsurge of the incidence of fungaemia in such communities has been noted with concern (Charles et al., 2003; Pappas et al., 2003; Peres-Bota et al., 2004) . This ubiquitous yeast is also the fourth most common cause of nosocomial blood-stream infection (Pappas et al., 2003; Rangel-Frausto et al., 1999) , and the agent of a significant proportion of crude (61 %) and attributable (49 %) mortality in critically ill patients in North America (Charles et al., 2003) .
It was recently estimated that Gram-negative bacteria are involved in half of the cases of sepsis (approx. 500 000 cases of sepsis) that occur annually in the USA. Up to 60 % of these cases tend to end in septic shock (Rangel-Frausto, 1999 ). Gram-negative bacterial LPS, a potent microbial toxin, and its proinflammatory properties are well known to play a critical role in the pathogenesis of such septic shock (Luchi & Morrison, 2000) .
Though C. albicans is the most commonly encountered organism from the genus Candida in clinical specimens, the incidence of non-albicans Candida is rising (Pappas et al., 2003; Peres-Bota et al., 2004; Rangel-Frausto et al., 1999; Snydman, 2003; Wisplinghoff et al., 2004) . Furthermore, there is evidence to indicate that bacterial co-infection or superinfection play a critical role in Candida infections (Bandara et al., 2009; Peres-Bota et al., 2004) . Some have also reported that Gram-negative bacterial LPS has direct (Bandara et al., 2009 ) and indirect effects (Henry-Stanley et al., 2003) on Candida biofilm formation, and on candidal infections.
We therefore evaluated the quantitative and qualitative effect of four different Gram-negative bacterial LPSs from P. aeruginosa, Serratia marcescens, K. pneumoniae and Salmonella typhimurium on various stages of biofilm development in six different human pathogenic Candida species. Our results are indicative that different LPSs modulate the various stages of biofilm development of specific Candida spp. to varying degrees.
Using the XTT reduction assay, we report here for what is believed to be the first time, the quantitative effects of four different bacterial LPS on six different Candida species at three different time points in biofilm development. When taken individually, each type of LPS tested here had significant effects, either inhibitory or stimulatory, on Candida species. In general, the effect elicited by LPS was time and concentration dependent. Salmonella and Pseudomonas LPS had the strongest overall effect on Candida, while Serratia LPS had the least. The effect of Pseudomonas LPS was mainly inhibitory while, the contrary was true for Salmonella LPS. When the phase of biofilm development was evaluated, Salmonella LPS had the strongest effect on Candida adhesion, being inhibitory in nature and the least effect was noted with Klebsiella LPS. Salmonella LPS effect was mixed, with the strongest effect on the initial candidal colonization (24 h) stage. Serratia LPS showed the weakest effect at this stage by only inhibiting C. krusei.
Pseudomonas LPS had the strongest suppressive effect on the maturation phase Candida biofilms. In contrast, Serratia and Salmonella LPS showed the highest, stimulatory, effect on the latter phase of Candida biofilms. Despite these specific variations, Salmonella LPS significantly inhibited the adhesion of Candida spp. at 100 and 10 mg ml
21
.
Bacterial LPS modulates Candida biofilms
In general, when the species-specific variations of Candida in response to LPS were considered, C. glabrata was the most susceptible to the LPS effect at any time point of biofilm development; C. albicans and C. tropicalis were the most resistant. At 90 min, the adhesion of C. glabrata was essentially inhibited by LPS. The effect was mixed at 24 h, while it was stimulatory at 48 h. Despite such speciesspecific findings, we noted that the initial colonization of C. albicans was significantly enhanced by 100 mg LPS ml 21 .
Our results substantiate the concept that Gram-negative bacterial LPSs in general have a direct modulatory effect on Candida biofilm development. The current data also validate the results of our previous study, which showed that E. coli LPS has a modulatory effect on Candida biofilm formation (Bandara et al., 2009) . In contrast, Palma et al. (1992) have reported that LPSs of E. coli, Serratia marcescens and Salmonella typhimurium had no direct effect on Candida growth at any concentration. ). Note the LPS-treated C. krusei biofilm is less organized with scattered cells compared to the control.
The phenotypic variations of LPS could be one important factor that affects its species-specific functional diversity. There is evidence, including the current observations, to support the concept that LPS diversity affects its biological activity. For instance, LPS activity can vary substantially depending upon both the type of the organism and the method of its extraction (Morrison & Leive, 1975) . The presence of outer-membrane proteins in association with LPS (Morrison et al., 1976) , the specific subunit composition of LPS (Vukajlovich & Morrison, 1985) and the presence of O-antigen carbohydrates that are linked to the LPS can all determine the quality of this lipid-carbohydrate complex. Sabra et al. (2003) explained that the phenotypic variations in the relative expression of two chemically distinct types of LPS of P. aeruginosa could be an important mechanism that alters surface characteristics in mediating adhesion and survival under extreme conditions (Makin & Beveridge, 1996; Sabra et al., 2003) . It should also be noted that, apart from such chemical properties, the method of LPS preparation may have an effect on its bioactivity and toxicity (Luchi & Morrison, 2000; Morrison & Leive, 1975) .
Although limited data are available on the effect of LPS in vitro, there are a number of in vivo studies demonstrating the variable effects of LPS on Candida. Burd et al. (1992) noted that when mice were injected with C. albicans along with viable E. coli or E. coli LPS intraperitoneally, both E. coli as well as LPS enhanced the virulence of C. albicans. In a similar study, Klaerner et al. (1997) also noted that mice injected with E. coli or LPS had increased number of C. albicans in kidney tissue suggesting the promotive effect of LPS on C. albicans (Akagawa et al., 1995) . As in the current study, species specificity of LPS appears to influence its outcome in the host. On the contrary, Hess et al. (2009) noted that the tissue burden of C. glabrata in mice was decreased in the presence of E. coli and its LPS. Henry-Stanley et al. (2003) demonstrated that LPS may protect against extraintestinal dissemination of orally inoculated C. albicans by inhibiting the adhesion of yeasts to intestinal epithelium.
It should be borne in mind that proinflammatory and immunomodulatory properties of LPS in vivo are major factors determining its indirect effect on Candida Rietschel et al., 1982) . Palma et al. (1992) noted in an in vitro study that LPS from E. coli, Serratia marcescens and Salmonella typhimurium, at doses from 1 to 100 ng ml
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, strongly enhanced the growth inhibition of C. albicans caused by human polymorphonuclear leukocytes.
Ultrastructural views of both LPS-treated and untreated Candida biofilms further confirmed the results of our XTT reduction assays. Generally, when a specific stage of Candida biofilm formation was suppressed by LPS, the biofilm tended to display a rather scanty architecture with a low proportion of budding yeasts, and a preponderance of dead and degrading cells. Candida blastospores were small in size and heterogeneous in shape in comparison to the more uniform, confluent, and relatively well-defined control biofilms. On the contrary, when a specific stage of Candida biofilm formation was stimulated by LPS, the biofilm was richly populated by more isoform blastospores and a large proportion of live and budding Candida, while the controls were devoid of such features.
In clinical terms, our data are indicative that individuals with systemic candidiasis superinfected with Gramnegative bacteria need prompt treatment to eradicate both types of organisms and to neutralize the action of LPS (Akagawa et al., 1995) . If indeed some form of LPS does modify the pathogenicity and virulence of Candida, as observed in our study, then it is tempting to suggest that a modified non-toxic form of LPS would be an alternative treatment option for reduction of the incidence of systemic candidiasis in high-risk patients (Henry-Stanley et al., 2003) .
In summary, our studies, focused mainly on the effect of various Gram-negative bacterial LPSs on different stages of Candida spp. biofilm development, are indicative that LPS has significant and direct modulatory effects on various stages of Candida biofilm development in a species-specific manner. It is also clear that some Candida species are able to withstand the effect of LPS more than others as the effect of LPS on Candida was specific and diverse. Further work is necessary to explain the molecular mechanisms underlying the species-specific response of Candida against LPS during biofilm formation, and to evaluate the role of LPS as a putative antifungal agent.
